Creating business success from life sciences
Glenn has a first degree in Genetics and a D Phil in Immunology. He qualified as a chartered accountant with Ernst & Young and worked in the life science practice for a number of years, advising a range of businesses as well as editing and co-authoring a number of the firm’s US, European and Global Life Science Reports.
He became CEO of BioCity Nottingham in 2003, growing it to be one of the largest bioscience incubators in Europe. He was a founder of R5 Pharmaceuticals, which was subsequently sold to Aesica, and he is a non-executive director of a number of other companies including Mobius Life Sciences, Xenogesis and Medilink East Midlands.
Toby is responsible for the day-to-day running of the site and services at BioCity. His career started in engineering and project management. After becoming chartered, he left engineering to start his first company in 2001 and since then has started and raised money for companies in financial services, digital media and business support. Latterly he ran the Growth Investment Network, a group of various funders and advisers. It was established to make business owners aware of the opportunities to raise finance and to collaborate to help get deals done.
Toby’s knowledge of the early stage investment and first-hand experience of starting and running early stage companies make him well placed to help the companies at BioCity.
Fraser Black joined BioCity Scotland from GE Life Sciences, where he was global services solutions director. Fraser oversees the collection of new bioscience and life sciences companies, including relationship-building with both corporate partners and the local community. He looks to build a world class hub of successful life science businesses in the central belt of Scotland, and believes there is potential to add real value to the economy.
He previously held VP positions with Amersham Bioscience in both bioscience services and sales and marketing. He was also president of Hoefer Pharmacia Biotech.